3.01.24
7 min. Read

HCPCS and CPT decisions. Akili results. Click trials

Issue 221

Welcome back to E&O: SaMD, a paying subscribers-only weekly newsletter focused on the world of digital pharma products, prescription digital therapeutics and other FDA-regulated digital health.

 E&O: Software as a Medical Device


Here's a quick rundown of things happening in FDA-regulated and pharma-focused digital health:

  • Akili shared its Q4 results with investors this week. The company had 11,571 active paying EndeavorOTC users

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Mahana Therapeutics’ insolvency. FDA clears Happy Ring (Tinder founder’s smart ring)
10.04.24
6 min. Read
Flashback: How Proteus Digital Health’s outcomes-based pricing worked for Tennessee Medicaid
9.20.24
5 min. Read
Are the Digital Mental Health Treatment G Codes necessary? Or RTM dupes?
7.12.24
7 min. Read
Which PDTs are still around? New bill in Congress.
6.28.24
10 min. Read
FDA OKs Alivecor (12L?), Akili OTC. Oui eyes obesity.
6.21.24
5 min. Read
Modern Health EAP pricing. Kellogg’s benefits.
6.07.24
8 min. Read
Digging into the Akili-Virtual Therapeutics deal
5.31.24
10 min. Read
CMS questions MedRhythms on InTandem
5.17.24
5 min. Read
Big Health GTM. Gabbi pricing. Oracle employee benefits
5.10.24
7 min. Read
MedRhythms-Alexion. Akili RCT for OTC.
4.26.24
6 min. Read
  • First
  • Previous
  • 1 of 37
  • Next
  • Last